The peroxisome proliferator-activated receptor α (PPARα): Role in hepatocarcinogenesis

Molecular and Cellular Endocrinology

Volumn 193, Issue 1-2, 2002, Pages 71-79

  Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Cytokines; Hepatocarcinogenesis; Kupffer cells; Oxidative stress; Peroxisome proliferators; PPAR

Indexed keywords

CARCINOGEN; CELL NUCLEUS RECEPTOR; CYTOKINE; ESTROGEN; FATTY ACID; FIBRIC ACID DERIVATIVE; HORMONE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLASTICIZER; SOLVENT; CELL RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL MODEL; APOPTOSIS; BIOASSAY; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; KUPFFER CELL; LIVER CARCINOGENESIS; METABOLIC ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; RODENT; ANIMAL; LIVER CELL CARCINOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; HUMANS; KUPFFER CELLS; PEROXISOME PROLIFERATORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0037205918     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00098-9     Document Type: Conference Paper

References (73)

1. Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling
2. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)
3. Mechanisms of estrogen-associated carcinogenesis
4. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia
5. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients
6. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
7. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
8. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
9. 2-generating peroxisomal fatty acyl-CoA oxidase
10. Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration
11. A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin
12. Alterations in DNA methylation may play a variety of roles in carcinogenesis
13. Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion
14. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment
15. The pleiotropic functions of peroxisome proliferator-activated receptor gamma
16. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma
17. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
18. Peroxisome proliferation due to di(2-ethylhexyl)phthalate (DEHP): species differences and possible mechanisms
19. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease
20. Morphometric study of human hepatic cell modifications induced by fenofibrate
21. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity
22. Potential roles of the peroxisome proliferator-activated receptor-gamma in macrophage biology and atherosclerosis
23. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer
24. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man
25. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression
26. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro
27. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
28. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet
29. Biological esterification of steroids
30. Cloning of novel members of the steroid hormone receptor superfamily
31. The interaction of C-17 esters of estradiol with the estrogen receptor
32. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator
33. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
34. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation
35. Progress in cardiovascular biology: PPAR for the course
36. In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway
37. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
38. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm
39. PPAR delta functions as a prostacyclin receptor in blastocyst implantation
40. Biochemical mechanisms of induction of hepatic peroxisome proliferation
41. Apoptosis in cancer
42. Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid
43. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
44. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer
45. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
46. Peroxisome proliferator activated receptor-alpha expression in human liver
47. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells
48. Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes
49. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
50. Role of peroxisome proliferator-activated receptor-α in altered cell cycle regulation in mouse liver
51. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)
52. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
53. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans
54. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis
55. Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect
56. Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation
57. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency
58. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators
59. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells
60. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants
61. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
62. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor
63. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
64. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene
65. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages
66. Peroxisome proliferator-activated receptor gamma and metabolic disease
67. Risk assessment of inhaled chloroform based on its mode of action
68. Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats
69. Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes
70. PPAR-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator
71. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver
72. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver